Dr. Sheikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
711 Canton Rd NE
Ste 300
Marietta, GA 30060Phone+1 678-741-5000Fax+1 678-819-4280
Education & Training
- Stony Brook Medicine/University HospitalFellowship, Gastroenterology, 1994 - 1997
- Baylor College of MedicineResidency, Internal Medicine, 1991 - 1994
- Aga Khan Medical CollegeClass of 1988
Certifications & Licensure
- GA State Medical License 2006 - 2025
- AL State Medical License 1998 - 2012
- PA State Medical License 1996 - 1998
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 244 citationsSofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a rand...Eric Lawitz, J. Lalezari, Tarek Hassanein, Kris V. Kowdley, Fred Poordad
The Lancet. Infectious Diseases. 2013-05-01 - 153 citationsCombination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim Sheikh
Hepatology. 2021-02-01 - 266 citationsSelonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trialsStephen A. Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, Natalie Bzowej, Raj Vuppalanchi
Journal of Hepatology. 2020-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: